December 20th, 2022, Wizbiotech Glycosylated Hemoglobin A1c and 25-hydroxy Vitamin D test kit obtain UKCA registration, which marks the possiblity to enpower British health management.

Xiamen Weizheng Biotechnology Co., LTD has been awarded the Export Commodity Brand Certificate issued by the China Council for the Promotion of International Trade. The success of this certificate for the company to build international brand image, enhance the company's international brand influence and competitiveness in the international market, help the company to efficiently develop overseas markets.

In order to provide our customers with better service and create a better office environment for our employees, Wiz moved to a new office area on August 28, 2022.

"Continuous Immune Analyzer WIZ-A202" independently developed by Xiamen Wiz Biotech Co., LTD obtained Fujian Medical Device Registration Certificate on March 31, 2017 [Min Instrument Registration: 20172400081].

We warmly celebrate the success of Xiamen Wiz Biotech Co., Ltd. in participating in the 14th China (International) Laboratory Medicine & Blood Transfusion Apparatus & Reagents Expo 2017 in Qingdao.

Xiamen Wiz Biotech Co., Ltd. was listed and traded on the New Third Board on February 5, 2017. The stock name is Wiz Biotech (stock code 839355).

The 2016 annual Awards & Dinner party was held in Xiamen Mingshi Jindian Seafood Hotel.

2016 Annual Conference of Laboratory Physicians of Chinese Medical Doctor Association and the 11th National Laboratory and Clinical Academic Conference was successfully held in Xiamen International Conference & Exhibition Center, Fujian Province from June 16 to 18, 2016.

Wiz Biotech has obtained ISO9001 and ISO13485 certificates in Jan 5th, 2016, which shows that our enterprise has a perfect quality management system.

In March 2013, Dr. Duan Xiaobo, director of research and development of Wiz Biotech, was selected as the fourth batch of high-level talents in Xiamen "Double Hundred Plan" A+ entrepreneurial and innovative talents.